SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023294
Filing Date
2020-11-10
Accepted
2020-11-10 07:30:34
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20200930_10q.htm 10-Q 733788
2 EXHIBIT 31.1 ex_208376.htm EX-31.1 11505
3 EXHIBIT 31.2 ex_208377.htm EX-31.2 11961
4 EXHIBIT 32.1 ex_208378.htm EX-32.1 4852
5 EXHIBIT 32.2 ex_208379.htm EX-32.2 4874
  Complete submission text file 0001437749-20-023294.txt   3749725

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcda-20200930.xml EX-101.INS 615236
7 XBRL TAXONOMY EXTENSION SCHEMA bcda-20200930.xsd EX-101.SCH 48208
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20200930_cal.xml EX-101.CAL 39189
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20200930_def.xml EX-101.DEF 304966
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20200930_lab.xml EX-101.LAB 263475
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20200930_pre.xml EX-101.PRE 331640
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 201299637
SIC: 2836 Biological Products, (No Diagnostic Substances)